This article is going to mainly focus on Earum Pharma Share Price Target 2025, 2026, 2028, 2030, 2040 and 2050. Along with this, we will also discuss the company’s Fundamental, sentiment, Income Report, Share Price history, and Quarterly Report. Our analysis will help investors in taking the right decision.
About Earum Pharma
Earum Pharma is a growing pharmaceutical company focused on developing innovative medicines. It aims to improve patient care by offering high-quality and affordable treatments. The company specializes in areas like chronic diseases, rare disorders, and generic drugs. Earum Pharma emphasizes research and development to create effective solutions for unmet medical needs.
With a strong commitment to ethics, Earum Pharma ensures its products meet global standards. It collaborates with healthcare professionals and researchers to deliver safe and reliable therapies. The company also prioritizes sustainability, reducing its environmental impact while serving communities.
Earum Pharma’s mission is to make healthcare accessible to all. By combining science, technology, and compassion, it strives to enhance lives worldwide. Its dedication to innovation and patient well-being makes it a trusted name in the pharmaceutical industry.
Earum Pharma Fundamental
Murae Organisor Ltd., established in 1912, operates in the pharmaceutical sector. The company’s market capitalization is ₹191 Cr, making it a small-cap stock. The company has reserves of ₹6.42 crore, which is relatively low. The company is listed on BSE with the code 542724.
Total revenue stood at ₹4.06 Crore in FY24, showing a negative jump of 75.18% over ₹16.36 Crore in FY23. Net profit accelerated to ₹0.05 Crore in FY24, showing a negative jump of 97.47% over FY23.
Also Read: Then don’t say that I didn’t tell you, buy Waaree Energies shares right now.
The Return on Equity (ROE) is 0.28%, and Return on Capital Employed (ROCE) is 0.79%. Both are very low, indicating poor efficiency in using capital. Debt to Equity ratio is 0.98, meaning the company relies almost equally on debt and equity. This is a concern as high debt can strain finances.
The trailing P/E ratio is 41.20, slightly higher than the industry P/E of 40.98. This suggests the stock is overvalued. At 0.61 P/B Ratio, it is below 1, indicating the stock may be undervalued based on its book value. Book Value per Share ₹3.35, which is higher than the current market price, but this alone does not guarantee good performance. The company has not paid any dividends recently, with a dividend yield of 0.00%. This is unattractive for income-seeking investors.
| Description | Value |
|---|---|
| Company Name | Murae Organisor Ltd. |
| Sector | Pharmaceuticals |
| Established | 1912 |
| Website | earumpharma.com |
| Listing At | BSE |
| BSE Code | 542724 |
| Mkt Cap | ₹191Cr |
| Reserves and Surplus | ₹6.42Cr |
| ROE | 0.28% |
| ROCE | 0.79% |
| 52 Week High | ₹3.03 |
| 52 Week Low | ₹1.04 |
| P/E Ratio (TTM) | 41.20 |
| Industry P/E | 40.98 |
| P/B Ratio | 0.61 |
| Face Value | 2 |
| Book Value Per Share | ₹3.35 |
| EPS (TTM) | ₹0.05 |
| Dividend Yield | 0.00% |
| Debt to Equity | 0.98 |
| Total Revenue | ₹4.06Cr |
| Revenue Growth | -75.18% |
| Net Profit (Anual) | ₹0.05Cr |
| Profit Growth | -97.47% |
Returns in Past Year
| Year | Returns (%) |
|---|---|
| 2024 | 85.71% |
| 2023 | -53.72% |
| 2022 | -71.02% |
| 2021 | 15.49% |
| 2020 | 97.54% |
Also Read: Tata Gold Price Target, money printing machine for small investors.
Earum Pharma Share Price Target 2025
The current sentiment of Earum Pharma is showing nuetral. the Earum Pharma share price target 2025 is going to be between Rs 1.30 to Rs 2.98.
| Year | Price Target (Min) | Price Target (Max) |
|---|---|---|
| 2025 | ₹1.30 | ₹2.98 |
Earum Pharma Share Price Target 2026
According to market experts, the price target of Earum Pharma for 2026 is going to be between Rs2.85 to Rs 3.45.
| Year | Price Target (Min) | Price Target (Max) |
|---|---|---|
| 2026 | ₹1.85 | ₹3.45 |
Also Read: Venus Pipes Share Price Target 2023 to 2050
Earum Pharma Share Price Target 2028
According to market experts, the price target of Earum Pharma for 2028 is going to be between Rs 2.65 to Rs 5.3.
| Year | Price Target (Min) | Price Target (Max) |
|---|---|---|
| 2028 | ₹2.65 | ₹5.3 |
Earum Pharma Share Price Target 2030
According to market experts, Earum Pharma Share Price Target 2030 is going to be between Rs3.86 to Rs 6.79.
| Year | Price Target (Min) | Price Target (Max) |
|---|---|---|
| 2030 | ₹3.86 | ₹6.79 |
Earum Pharma Share Price Target 2040
According to the past trend of the company, Earum Pharma Share Price Target 2040 is going to be between Rs 10.6 to Rs 17.80.
| Year | Price Target (Min) | Price Target (Max) |
|---|---|---|
| 2040 | ₹10.6 | ₹17.80 |
Also Read: Adani Power price target, share will increase 10 times.
Earum Pharma Share Price Target 2050
According to the past trend of the company, Earum Pharma Share Price Target 2050 is going to be between Rs 15.4 to Rs 30.7.
| Year | Price Target (Min) | Price Target (Max) |
|---|---|---|
| 2050 | ₹15.4 | ₹30.7 |
Strengths
- The trailing P/E ratio is 41.20, slightly higher than the industry P/E of 40.98. This suggests the stock is overvalued.
- Book Value per Share ₹3.35, which is higher than the current market price
- Established in 1912, the company has a long-standing presence in the pharmaceutical sector.
- The price-to-book ratio of 0.61 suggests the stock may be undervalued.
- In 2022, the company generated ₹2.61 crore from operating activities, showing some improvement.
Risks
- Revenue and profit have fallen sharply over the years. This raises concerns about the company’s ability to grow.
- A debt-to-equity ratio of 0.98 indicates reliance on debt, which can be risky if earnings do not improve.
- In some quarters, the company reported negative profit margins, such as -104.35% in March 2024.
- The low returns on equity and capital employed show inefficiency in using resources.
- The lack of dividends makes the stock less appealing to income-focused investors.
- The company has reserves of ₹6.42 crore, which is relatively low.
Also Read: Tata Steel price target, trust of more than 100 years old company.
Earum Pharma Quarterly Income Report
| Description | Sep 24 | Jun 24 | Mar 24 | Dec23 |
| Revenue + | ₹281.05Cr. | ₹58.01Cr. | ₹0.23Cr. | ₹0.40Cr. |
| Expenses + | ₹275.79Cr | ₹56.89Cr. | ₹0.47Cr. | ₹0.37Cr. |
| EBITDA | ₹5.26Cr | ₹1.12Cr. | ₹-0.24Cr. | ₹0.06Cr. |
| EBIT | ₹5.26Cr | ₹1.12Cr. | ₹-0.24Cr. | ₹0.04Cr. |
| Net Profit | ₹4.01Cr | ₹0.90Cr. | ₹-0.24Cr. | ₹0.04Cr. |
| Operating Profit Margin | 1.87% | 1.95% | -104.35% | 15% |
| Net Profit Margin | 1.43% | 1.55% | -104.35% | 10% |
| Earning Per Share | ₹0.06 | ₹0.01 | ₹-0.01 | ₹0.05 |
| Dividends Per Share | 0.00 | 0.00 | 0.00 | 0.70 |
Earum Pharma Annual Income Report
| Description | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|
| Total Revenue | ₹4.06Cr | ₹16.36Cr | ₹28.74Cr | ₹50.02Cr |
| Total Expenses | ₹3.99Cr | ₹13.56Cr | ₹25.66Cr | ₹49.90Cr |
| Profit/Loss | ₹0.05Cr | ₹1.98Cr | ₹2.22Cr | ₹0.09Cr |
| Net Profit Margin | 1.97% | 14.05% | 10.55% | 0.22% |
| Earning Per Share | ₹0.00 | ₹0.32 | ₹0.36 | ₹0.01 |
| EBITDA | ₹0.39 | ₹3.19 | ₹3.28 | ₹1.17 |
| EBIT | ₹0.34 | ₹3.09 | ₹3.16 | ₹1.05 |
| Operating Profit Margin | 15.35% | 22.64% | 15.59% | 2.85% |
| Dividends Per share | 0.00 | 0.00 | 0.00 | 0.00 |
Earum Pharma Cash Flow
| Particulars | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|
| Opening Cash Balance | ₹-1.24Cr. | ₹0.03Cr. | ₹0.16Cr. | ₹0.02Cr. |
| Cash Flow From Operating Activities | ₹2.61Cr | ₹-7.10Cr. | ₹-3.45Cr. | ₹-0.48Cr. |
| Cash Flow From Investing Activities | ₹0.06Cr | ₹2.94Cr. | ₹-3.45Cr. | ₹-0.32Cr. |
| Cash Flow From Financing Activities | ₹-2.59Cr | ₹-2.90Cr. | ₹-6.76Cr. | ₹-0.94Cr. |
| Closing Cash Balance | ₹-1.15Cr | ₹-1.24Cr. | ₹0.03Cr. | ₹0.16Cr. |
| Net Change In Cash | ₹0.08 | ₹-1.26 | ₹-0.14 | ₹0.14 |
Earum Pharma Share Price History Chart
Earum Pharma Share Price Target 2025, 2026, 2028, 2030, 2040 to 2050
| Year | Price Target (Min) | Price Target (Max) |
|---|---|---|
| 2025 | ₹1.30 | ₹2.98 |
| 2026 | ₹1.85 | ₹3.45 |
| 2028 | ₹2.65 | ₹5.3 |
| 2030 | ₹3.86 | ₹6.79 |
| 2040 | ₹10.6 | ₹17.80 |
| 2050 | ₹15.4 | ₹30.7 |
Also Read: SW Solar price target, guarantee boom in solar sector.
Earum Pharma Shareholding Pattern
| Shareholder | Share % |
|---|---|
| Retail and Others | 100% |
| Total | 100.00% |
How to Buy BEL Shares?
Buying and selling of Earum Pharma can be done by a stock broker registered with SEBI. Here are the names of some popular brokers.
- groww
- Zerodha
- Angel One
- upstox
Earum Pharma Similar Stocks
| Company Name | Mkt Cap | Profit (1Year) | 52W L | 52W H |
|---|---|---|---|---|
| Kaynes Technology India | ₹39.80KCr. | 124.99% | ₹2424 | ₹7822 |
| Hindustan Aeronautics | ₹2.56LCr. | 22.77% | ₹2820 | ₹5674.75 |
| Boeing Co | ₹12.70 KCr. | 15.74% | ₹137.03 | ₹217.59 |
| Airbus SE | ₹12.38KCr | 6.05% | ₹124.72 | ₹172.78 |
| Bharat Dynamics | ₹42.29 KCr | 31% | ₹776.05 | ₹1794.70 |
| Apollo Micro Systems | ₹3.94 KCr. | 4.75% | ₹87.99 | ₹147.55 |
| Bharat Electronics | ₹1.97 KCr | 43.07% | ₹171.70 | ₹340.35 |
Earum Pharma Share Price Target: Export Opinion
Profitable Stocks
| Stocks | Mkt cap | Profit (1Year) | 52W L | 52W H |
|---|---|---|---|---|
| Adani ports | ₹3.11 LCr | 94.78% | ₹703.00 | ₹1,457.05 |
| Adani Enterprises | ₹3.89 LCr | 40.35% | ₹2142.00 | ₹3457.85 |
| Suzlon Energy | ₹90.75 KCr | 85.69% | ₹33.90 | ₹86.04 |
| Tata Power Company | ₹1.44 LCr | 101.76% | ₹215.70 | ₹464.20 |
| Adani Power | ₹2.92 LCr | 192.93% | ₹231.00 | ₹797.00 |
| Havells India | ₹1.20 LCr | 41.69% | ₹1232.85 | ₹1950.05 |
| Tata Motors | ₹3.57 LCr | 72.86% | ₹557.70 | ₹1065.60 |
| Tata Power | ₹1.44 LCr | 75.52% | ₹230.80 | ₹494.85 |
Conclusion
Murae Organisor Ltd. has a long history, but its financial performance is weak. The company faces significant challenges, including declining revenue, high debt, and low profitability. While the low P/B ratio might suggest undervaluation, the poor fundamentals make it a risky investment.
For long-term investors, this stock may not be suitable unless the company shows clear signs of improvement in revenue, profit margins, and debt management. Until then, it is better to avoid this stock and look for more stable and growing companies in the pharmaceutical sector.
Disclaimer– Please note that all the information given here is for general information purpose only and not for investment purposes. Therefore, before investing in any share, take advice from a certified market expert. If you invest, you will be responsible for your profits and losses.
Also Read:
Then don’t say that I didn’t tell you, buy Waaree Energies shares right now.
Tata Gold Price Target, money printing machine for small investors.
Adani Power price target, share will increase 10 times.
Tata Steel price target, trust of more than 100 years old company.
SW Solar price target, guarantee boom in solar sector.
Tata Power share price target, guaranteed returns.
Yatra Online shares will make you rich, 100% guarantee.
Den Networks Share Price Target 2024, to 2050
Venus Pipes Share Price Target 2023 to 2050
Q1. What is the Earum Pharma share price target 2025?
Ans: 2025 price target of Earum Pharma will be between Rs.1.30 to Rs.2.98.
Q2. What is the Earum Pharma share price target 2030?
Ans: BEL will trade between Rs 3.86 and Rs 6.79 in 2030.
Q4. What is the Earum Pharma share price target 2040?
Ans: 2040 price target of Earum Pharma will be between Rs.10.6 to Rs.17.80.
Q5. What is the Earum Pharma share price target 2050?
Ans: 2050 price target of Earum Pharma will be between Rs.15.4 to Rs.30.7.